Overland Pharmaceuticals
Ed Zhang's work experience includes:
- Co-founder and CEO of Overland Pharmaceuticals since January 2022.
- Interim CEO of Overland Pharmaceuticals from May 2021 to January 2022.
- Co-Founder, COO & CBO of Overland Pharmaceuticals from February 2020 to May 2021.
- Venture Partner, HH Bioventure at Hillhouse Capital Management since January 2020.
- Vice President of Corporate Development at Boston Pharmaceuticals from an unknown start date to January 2020.
- Senior Director of Business Development at ImmunoGen, Inc. from an unknown start date to an unknown end date.
- Senior Director, Global Business Development at Sanofi from an unknown start date to an unknown end date.
- Director, Commercial Operations and Strategic Development at Sanofi from an unknown start date to an unknown end date.
- Associate Director, Business Development at Sanofi from an unknown start date to an unknown end date.
- Business Development Manager at Sanofi from an unknown start date to an unknown end date.
- Senior Research Associate at Abbott Laboratories from an unknown start date to an unknown end date.
- Associate Scientist at Pharmacia from an unknown start date to an unknown end date.
Ed Zhang's education history includes earning an M.B.A. from Northwestern University - Kellogg School of Management, with coursework in finance, marketing, and biotechnology. Ed also holds an M.S. in organic chemistry from Binghamton University and a B.S. in chemistry from Nanjing University.
This person is not in any offices
Overland Pharmaceuticals
Founded in 2020, Overland Pharmaceuticals is establishing a leading cross-border platform company focused on advanced modalities through strategic partnering and in-house R&D. Overland is seeded by Hillhouse Capital with access to global innovation and China biopharma ecosystem. Overland is building an initial oncology portfolio of first-in-class ADC and allogeneic cell therapy programs for greater China and Asia through partnering with established biotechs. Through formative R&D partnerships and in-house technology platforms, Overland will move forward the development and commercialization of the most promising advances in medicine.